0
Skip to Content
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
ICCFOP
ICC Members
ICC Committees
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
Folder: About Us
Back
ICC Members
ICC Committees
Contact
Folder: Treatment Guidelines
Back
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
Folder: Patients
Back
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Folder: Industry
Back
Clinical Trial Committee Chair
Folder: Healthcare Providers
Back
FOP Doctors and Specialists
Link to Clinical Trials
Folder: Media
Back
FOP Publications
FOP Presentations
Press Releases
Member Login
Emergency Info
Civiane Chung 2025-07-31 Civiane Chung 2025-07-31

GUIDELINES HOME

Read More
Civiane Chung 2025-01-09 Civiane Chung 2025-01-09

INTRODUCTION

Read More
Civiane Chung 2025-01-08 Civiane Chung 2025-01-08

1. ABSTRACT

Read More
Civiane Chung 2025-01-07 Civiane Chung 2025-01-07

2. EXECUTIVE SUMMARY OF KEY PRACTICE POINTS 

Read More
Civiane Chung 2025-01-07 Civiane Chung 2025-01-07

3. THE CLINICAL AND BASIC SCIENCE BACKGROUND OF FOP 

Read More
Civiane Chung 2025-01-06 Civiane Chung 2025-01-06

4. THE PATHOLOGIC AND PATHOPHYSIOLOGIC-BASED TREATMENT OF FOP 

Read More
Civiane Chung 2024-12-28 Civiane Chung 2024-12-28

5. SPECIAL MEDICAL CONSIDERATIONS IN FOP

Read More
Civiane Chung 2024-12-27 Civiane Chung 2024-12-27

6. CURRENT TREATMENT CONSIDERATIONS 

Read More
Civiane Chung 2024-12-25 Civiane Chung 2024-12-25

7. CLASSES OF MEDICATIONS

Read More
Civiane Chung 2024-12-24 Civiane Chung 2024-12-24

8. EMERGENCY GUIDELINES FOR FIRST RESPONDERS, PHYSICIANS & DENTISTS

Read More
Civiane Chung 2024-12-23 Civiane Chung 2024-12-23

9. CONCLUSIONS

Read More
Civiane Chung 2024-12-22 Civiane Chung 2024-12-22

10. ACKNOWLEDGMENTS

Read More
Civiane Chung 2024-12-18 Civiane Chung 2024-12-18

11. DISCLOSURES

Read More
Civiane Chung 2024-12-16 Civiane Chung 2024-12-16

12. AUTHORS’ CONTACT INFORMATION

Read More

Join our mailing list

Sign up to receive updates from us.

© 2025 The International Clinical Council (ICC) on Fibrodysplasia Ossificans Progressiva (FOP).